Important Selected Safety Information

VEREGEN^® has not been evaluated to treat urethral, intra-vaginal, cervical, rectal, or intra-anal human papilloma viral disease and should not be used to treat these conditions. Avoid use of VEREGEN^® on open wounds.

Avoid exposure of VEREGEN^®-treated areas to sun/UV-light because VEREGEN^® has not been tested under these circumstances. Safety and efficacy of VEREGEN^® have not been established in immunosuppressed patients or patients under 18 years of age, or for the treatment of external genital and perianal warts beyond 16 weeks or for multiple treatment courses.

The most common adverse reactions are local skin and application site reactions including (incidence ≥ 20%) erythema, pruritus, burning, pain/discomfort, erosion/ulceration, edema, induration, and rash vesicular.

VEREGEN^® (sinecatechins) Ointment Full Prescribing Information